<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36268734</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1560-7917</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>42</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</Title><ISOAbbreviation>Euro Surveill</ISOAbbreviation></Journal><ArticleTitle>Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2200157</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.2807/1560-7917.ES.2022.27.42.2200157</ELocationID><Abstract><AbstractText>BackgroundAcute flaccid myelitis (AFM) is a polio-like condition affecting mainly children and involving the central nervous system (CNS). AFM has been associated with different non-polio-enteroviruses (EVs), in particular EV-D68 and EV-A71. Reliable incidence rates in European countries are not available.AimTo report AFM incidence in children in the Netherlands and its occurrence relative to EV-D68 and EV-A71 detections.MethodsIn 10 Dutch hospitals, we reviewed electronic health records of patients diagnosed with a clinical syndrome including limb weakness and/or CNS infection and who were&#x2009;&lt;&#x2009;18&#x2009;years old when symptoms started. After excluding those with a clear alternative diagnosis to AFM, those without weakness, and removing duplicate records, only patients diagnosed in January 2014-December 2019 were retained and further classified according to current diagnostic criteria. Incidence rates were based on definite and probable AFM cases. Cases' occurrences during the study period were co-examined with laboratory-surveillance detections of EV-D68 and EV-A71.ResultsAmong 143 patients included, eight were classified as definite and three as probable AFM. AFM mean incidence rate was 0.06/100,000 children/year (95%&#x2009;CI:&#x2009;-0.03 to 0.14). All patient samples were negative for EV-A71. Of respiratory samples in seven patients, five were EV-D68 positive. AFM cases clustered in periods with increased EV-D68 and EV-A71 detections.ConclusionsAFM is rare in children in the Netherlands. The temporal coincidence of EV-D68 circulation and AFM and the detection of this virus in several cases' samples support its association with AFM. Increased AFM awareness among clinicians, adequate diagnostics and case registration matter to monitor the incidence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Helfferich</LastName><ForeName>Jelte</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Lange</LastName><ForeName>Marit Ma</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benschop</LastName><ForeName>Kimberley Sm</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacobs</LastName><ForeName>Bart C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Department of Neurology and Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Leer-Buter</LastName><ForeName>Coretta C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meijer</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakker</LastName><ForeName>Dewi P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Amsterdam University Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Bie</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Amsterdam University Medical Center, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braakman</LastName><ForeName>Hilde Mh</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandsma</LastName><ForeName>Rick</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, University Medical Center Utrecht, Utrecht, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neuteboom</LastName><ForeName>Rinze F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Department of Neurology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niks</LastName><ForeName>Erik H</ForeName><Initials>EH</Initials><AffiliationInfo><Affiliation>Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niermeijer</LastName><ForeName>Jikke-Mien</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roelfsema</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Martini Hospital, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schoenmaker</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Isala Hospital, Zwolle, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sie</LastName><ForeName>Lilian T</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Paediatric Neurology, Haga Hospital, the Hague, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niesters</LastName><ForeName>Hubert G</ForeName><Initials>HG</Initials><AffiliationInfo><Affiliation>Department of Medical Microbiology and Infection Prevention, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouwer</LastName><ForeName>Oebele F</ForeName><Initials>OF</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Te Wierik</LastName><ForeName>Margreet Jm</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Sweden</Country><MedlineTA>Euro Surveill</MedlineTA><NlmUniqueID>100887452</NlmUniqueID><ISSNLinking>1025-496X</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000629404">acute flaccid myelitis</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009187" MajorTopicYN="Y">Myelitis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020805" MajorTopicYN="Y">Central Nervous System Viral Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D030016" MajorTopicYN="Y">Enterovirus D, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute flaccid myelitis</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">enterovirus D68</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">surveillance</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> Jelte Helfferich, Marit M.A. de Lange, Kimberley S.M. Benschop, Bart C. Jacobs, Coretta C. Van Leer-Buter, Adam Meijer, Dewi P. Bakker, Eva de Bie, Hilde M.H. Braakman, Rick Brandsma, Rinze F. Neuteboom, Erik H. Niks, Jikke-Mien Niermeijer, Vincent Roelfsema, Niels Schoenmaker, Lilian T. Sie, Hubert G. Niesters, Oebele F. Brouwer, Margreet J.M. te Wierik declare no potential conflict of interest in relation to this study.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36268734</ArticleId><ArticleId IdType="pmc">PMC9585879</ArticleId><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.42.2200157</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Murphy OC, Messacar K, Benson L, Bove R, Carpenter JL, Crawford T, et al. Acute flaccid myelitis: cause, diagnosis, and management. Lancet. 2021;397(10271):334-46. 10.1016/S0140-6736(20)32723-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32723-9</ArticleId><ArticleId IdType="pmc">PMC7909727</ArticleId><ArticleId IdType="pubmed">33357469</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Asturias EJ, Hixon AM, Van Leer-Buter C, Niesters HGM, Tyler KL, et al. Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality. Lancet Infect Dis. 2018;18(8):e239-47. 10.1016/S1473-3099(18)30094-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(18)30094-X</ArticleId><ArticleId IdType="pmc">PMC6778404</ArticleId><ArticleId IdType="pubmed">29482893</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, et al. Pan-viral serology implicates enteroviruses in acute flaccid myelitis. Nat Med. 2019;25(11):1748-52. 10.1038/s41591-019-0613-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-019-0613-1</ArticleId><ArticleId IdType="pmc">PMC6858576</ArticleId><ArticleId IdType="pubmed">31636453</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Spence-Davizon E, Osborne C, Press C, Schreiner TL, Martin J, et al. Clinical characteristics of enterovirus A71 neurological disease during an outbreak in children in Colorado, USA, in 2018: an observational cohort study. Lancet Infect Dis. 2020;20(2):230-9. 10.1016/S1473-3099(19)30632-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30632-2</ArticleId><ArticleId IdType="pmc">PMC11284833</ArticleId><ArticleId IdType="pubmed">31859216</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyda A, Stelzer-Braid S, Adam D, Chughtai AA, MacIntyre CR. The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation? Euro Surveill. 2018;23(3). 10.2807/1560-7917.ES.2018.23.3.17-00310</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2018.23.3.17-00310</ArticleId><ArticleId IdType="pmc">PMC5792700</ArticleId><ArticleId IdType="pubmed">29386095</ArticleId></ArticleIdList></Reference><Reference><Citation>Yea C, Bitnun A, Robinson J, Mineyko A, Barton M, Mah JK, et al. Longitudinal outcomes in the 2014 acute flaccid paralysis cluster in Canada. J Child Neurol. 2017;32(3):301-7. 10.1177/0883073816680770</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073816680770</ArticleId><ArticleId IdType="pubmed">28193112</ArticleId></ArticleIdList></Reference><Reference><Citation>Messacar K, Schreiner TL, Van Haren K, Yang M, Glaser CA, Tyler KL, et al. Acute flaccid myelitis: A clinical review of US cases 2012-2015. Ann Neurol. 2016;80(3):326-38. 10.1002/ana.24730</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24730</ArticleId><ArticleId IdType="pmc">PMC5098271</ArticleId><ArticleId IdType="pubmed">27422805</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay SL, Lee AD, Lopez AS, Nix WA, Dooling KL, Keaton AA, et al. Increase in acute flaccid myelitis - United States, 2018. MMWR Morb Mortal Wkly Rep. 2018;67(45):1273-5. 10.15585/mmwr.mm6745e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6745e1</ArticleId><ArticleId IdType="pmc">PMC6290805</ArticleId><ArticleId IdType="pubmed">30439867</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Benschop KSM, Berginc N, Midgley S, Wolthers K, Simmonds P, et al. European Non-Polio Enterovirus Network: Introduction of hospital-based surveillance network to understand the true disease burden of non-polio enterovirus and parechovirus infections in Europe. Microorganisms. 2021;9(9):1827. 10.3390/microorganisms9091827</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9091827</ArticleId><ArticleId IdType="pmc">PMC8469463</ArticleId><ArticleId IdType="pubmed">34576722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bubba L, Broberg EK, Jasir A, Simmonds P, Harvala H, Redlberger-Fritz M, et al. Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. Lancet Infect Dis. 2020;20(3):350-61. 10.1016/S1473-3099(19)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30566-3</ArticleId><ArticleId IdType="pubmed">31870905</ArticleId></ArticleIdList></Reference><Reference><Citation>Poelman R, Schuffenecker I, Van Leer-Buter C, Josset L, Niesters HGM, Lina B, et al. European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014. J Clin Virol. 2015;71:1-9. 10.1016/j.jcv.2015.07.296</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2015.07.296</ArticleId><ArticleId IdType="pubmed">26364237</ArticleId></ArticleIdList></Reference><Reference><Citation>Midgley SE, Benschop K, Dyrdak R, Mirand A, Bailly JL, Bierbaum S, et al. Co-circulation of multiple enterovirus D68 subclades, including a novel B3 cluster, across Europe in a season of expected low prevalence, 2019/20. Euro Surveill. 2020;25(2):1900749. 10.2807/1560-7917.ES.2020.25.2.1900749</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.2.1900749</ArticleId><ArticleId IdType="pmc">PMC6976881</ArticleId><ArticleId IdType="pubmed">31964463</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoester M, Helfferich J, Poelman R, Van Leer-Buter C, Brouwer OF, Niesters HGM, et al. Twenty-nine cases of enterovirus-D68-associated acute flaccid myelitis in Europe 2016: A case series and epidemiologic overview. Pediatr Infect Dis J. 2019;38(1):16-21. 10.1097/INF.0000000000002188</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002188</ArticleId><ArticleId IdType="pmc">PMC6296836</ArticleId><ArticleId IdType="pubmed">30234793</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Sanz R, Casas-Alba D, Launes C, Mu&#xf1;oz-Almagro C, Ruiz-Garc&#xed;a MM, Alonso M, et al. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016. Euro Surveill. 2019;24(7):1800089. 10.2807/1560-7917.ES.2019.24.7.1800089</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.7.1800089</ArticleId><ArticleId IdType="pmc">PMC6381658</ArticleId><ArticleId IdType="pubmed">30782267</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CJ, Thomas RH, Pickersgill TP, Lyons M, Lowe G, Stiff RE, et al. Cluster of atypical adult Guillain-Barr&#xe9; syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016. Euro Surveill. 2016;21(4):30119. 10.2807/1560-7917.ES.2016.21.4.30119</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.4.30119</ArticleId><ArticleId IdType="pubmed">26848143</ArticleId></ArticleIdList></Reference><Reference><Citation>The United Kingdom Acute Flaccid Paralysis Afp Task Force . An increase in reports of acute flaccid paralysis (AFP) in the United Kingdom, 1 January 2018-21 January 2019: early findings. Euro Surveill. 2019;24(6):1900093. 10.2807/1560-7917.ES.2019.24.6.1900093</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.6.1900093</ArticleId><ArticleId IdType="pmc">PMC6373064</ArticleId><ArticleId IdType="pubmed">30755296</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A, van der Sanden S, Snijders BEP, Jaramillo-Gutierrez G, Bont L, van der Ent CK, et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology. 2012;423(1):49-57. 10.1016/j.virol.2011.11.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.11.021</ArticleId><ArticleId IdType="pubmed">22177700</ArticleId></ArticleIdList></Reference><Reference><Citation>Meijer A, Benschop KS, Donker GA, van der Avoort HG. Continued seasonal circulation of enterovirus D68 in the Netherlands, 2011-2014. Euro Surveill. 2014;19(42):20935. 10.2807/1560-7917.ES2014.19.42.20935</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.42.20935</ArticleId><ArticleId IdType="pubmed">25358039</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KS, Rahamat-Langendoen JC, van der Avoort HG, Claas EC, Pas SD, Schuurman R, et al. VIRO-TypeNed, systematic molecular surveillance of enteroviruses in the Netherlands between 2010 and 2014. Euro Surveill. 2016;21(39):30352. 10.2807/1560-7917.ES.2016.21.39.30352</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.39.30352</ArticleId><ArticleId IdType="pmc">PMC5069426</ArticleId><ArticleId IdType="pubmed">27719752</ArticleId></ArticleIdList></Reference><Reference><Citation>Niesters HG, Rossen JW, van der Avoort H, Baas D, Benschop K, Claas EC, et al. Laboratory-based surveillance in the molecular era: the TYPENED model, a joint data-sharing platform for clinical and public health laboratories. Euro Surveill. 2013;18(4):20387. 10.2807/ese.18.04.20387-en</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/ese.18.04.20387-en</ArticleId><ArticleId IdType="pubmed">23369392</ArticleId></ArticleIdList></Reference><Reference><Citation>Donker G. NIVEL Zorgregistraties Eerste Lijn - Peilstations 2018. [Nivel Primary Care Registrations - Sentinel Stations 2018.]. Utrecht: Nivel; 2019.</Citation></Reference><Reference><Citation>Donker GA. NIVEL Primary Care Database - Sentinel Practices. 2015. Utrecht: Nivel; 2019.</Citation></Reference><Reference><Citation>van Dissel JT, Meijer A. Enterovirus type D68 en acute slappe verlamming: een nieuw duo? Ned Tijdschr Geneeskd. 2017;161:D1825.</Citation><ArticleIdList><ArticleId IdType="pubmed">28832298</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane MS, Sonne C, Zhu S, Malhotra A, Van Haren K, Messacar K, et al. Incidence, risk factors and outcomes among children with acute flaccid myelitis: a population-based cohort study in a California Health Network between 2011 and 2016. Pediatr Infect Dis J. 2019;38(7):667-72. 10.1097/INF.0000000000002276</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000002276</ArticleId><ArticleId IdType="pubmed">30985511</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Haren K, Ayscue P, Waubant E, Clayton A, Sheriff H, Yagi S, et al. Acute flaccid myelitis of unknown etiology in California, 2012-2015. JAMA. 2015;314(24):2663-71. 10.1001/jama.2015.17275</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.17275</ArticleId><ArticleId IdType="pubmed">26720027</ArticleId></ArticleIdList></Reference><Reference><Citation>Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, et al. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro Surveill. 2016;21(46). 10.2807/1560-7917.ES.2016.21.46.30402</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.46.30402</ArticleId><ArticleId IdType="pmc">PMC5144948</ArticleId><ArticleId IdType="pubmed">27918268</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Lopez AS, Cortese MM, Leshem E, Pastula DM, Miller L, et al. Acute flaccid myelitis in the United States, August-December 2014: Results of nationwide surveillance. Clin Infect Dis. 2016;63(6):737-45. 10.1093/cid/ciw372</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciw372</ArticleId><ArticleId IdType="pmc">PMC5709818</ArticleId><ArticleId IdType="pubmed">27318332</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijstens AL, Lechner C, Flet-Berliac L, Deiva K, Neuteboom RF, Hemingway C, et al. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. Eur J Paediatr Neurol. 2020;29:2-13. 10.1016/j.ejpn.2020.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2020.10.006</ArticleId><ArticleId IdType="pubmed">33162302</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JA, Messacar K, Yang ML, Maloney JA, Lindwall J, Carry T, et al. Outcomes of Colorado children with acute flaccid myelitis at 1 year. Neurology. 2017;89(2):129-37. 10.1212/WNL.0000000000004081</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004081</ArticleId><ArticleId IdType="pmc">PMC5501931</ArticleId><ArticleId IdType="pubmed">28615421</ArticleId></ArticleIdList></Reference><Reference><Citation>Benschop KS, Albert J, Anton A, Andr&#xe9;s C, Aranzamendi M, Armannsd&#xf3;ttir B, et al. Re-emergence of enterovirus D68 in Europe after easing the COVID-19 lockdown, September 2021. Euro Surveill. 2021;26(45):2100998. 10.2807/1560-7917.ES.2021.26.45.2100998</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.45.2100998</ArticleId><ArticleId IdType="pmc">PMC8646978</ArticleId><ArticleId IdType="pubmed">34763750</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Broberg E, Benschop K, Berginc N, Ladhani S, Susi P, et al. Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. J Clin Virol. 2018;101:11-7. 10.1016/j.jcv.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2018.01.008</ArticleId><ArticleId IdType="pubmed">29414181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>